Clinical Trial Supply East Coast 2022

Our Annual Clinical Trial Supply East Coast will take place on the 11th and 12th October 2023 in King of Prussia.

19 - 20

October

2022
  • King of Prussia, PA, USA
  • Complimentary
  • Why attend?
  • Agenda
  • 2022 Speakers
  • Event Gallery
  • 2022 Sponsors
  • Media Centre
  • Contact Us

Why attend?

Bringing together Pharma and Biotech experts to discuss new trends and opportunities

The Clinical Trial Supply East Coast is the meeting place for the pharmaceutical and biotechnology community to discover how to excel in clinical supply strategy as well as form key connections for long-term success.

It’s time to build relationships and take away valuable lessons to for clinical trial success moving forward so we look forward to seeing you there!

300+

Attendees

35+

Exhibitors

20+

Speakers

300+

Attendees

35+

Exhibitors

20+

Speakers

See What It's All About

Agenda

  • 19 Oct 2022
  • 20 Oct 2022
Expand All

Streams

Stream one

Clinical Supply Operations Stream

Stream two

Clinical Supply Technology and Innovation Stream

9 AM

CORE Elements of a Clinical Supply Project Manager

  • Key areas to focus on to become a successful Clinical Supply Project Manager
  • Core competencies and skillsets of a Clinical Supply Project Manager
  • Understanding the supply chain from a Clinical Supply Project Managers point of view

Speakers

Francesco Santo
Associate Director, Clinical Supplies, Exelixis

11:15 AM

Deconstructing modern day labelling of investigational drugs

  • Innovation in labelling has changed the game but has it made things easier.
  • With the extra demand to go bigger with trials and pool supplies, can we keep up and does Just in Time labelling help.
  • How to effectively plan for a smooth international trial.
  • Should you leave label translation up to your CRO.

7:45 AM

Registration and refreshments

8:15 AM

Clinical Supply Technology and Innovation Stream

8:25 AM

Chairs opening remarks

8:50 AM

Chairs opening remarks

2022 Speakers

Select a speaker to learn more

Back
Jeff Clement
Executive Director, CDMO Business Development North America, PCI Pharma Services

Jeff joined PCI in 2014 and he manages the North American Business Development Team for PCI’s Manufacturing and Development services.  Jeff has over twenty-five years in the biotech and pharmaceutical industries and his career includes experience in the pharmaceutical discovery sciences, high throughput automation, clinical formulation development, and cGMP analytical and manufacturing contract services.  All his business development experience is in the aseptic manufacturing and analytical fields. Prior to his current role, Jeff was previously the Director of Global Business Development at AMRI (Drug Product). Jeff received a B.S. in Biology from Keene State College and a M.S. in Quality Systems from The New England College of Business.

Next speaker
Back
Ian Hoban
Business Development Director, Abacus Medicine

Ian has over 30 years of pharmaceutical industry experience, predominantly within global organisations such as Pfizer and Eli Lilly.  He built his reputation in the commercialisation of numerous brands in a variety of disease areas, and at every stage of the product lifecycle.

During his career, Ian has worked closely with supply chain, ensuring accurate forecasting, and getting medicines to patients through the implementation of novel approaches.

Before joining Abacus Medicine Pharma Services Ian worked in senior roles at two leading global clinical solutions companies.  He provided many leading pharmaceutical and biotechnology companies with successful comparator sourcing solutions which helped successfully deliver their pivotal late phase clinical trials.

Next speaker
Back
Tom Skiendzielewski
Associate Director Business Process And Integration, Takeda Pharmaceuticals

Tom is currently serving as the Associate Director of Business Process and Integration in Takeda’s Clinical Supply Chain  group within the Lexington, MA office.  Within this role, he is responsible for the optimization and utilization of the in-house Clinical Supply Management Database (SmartSupplies) currently deployed for all of Takeda’s clinical trials managed out of the Lexington, MA office.  In addition, Tom is also responsible for the Clinical Supply chain integration activities related to any mergers and / or acquisitions made by Takeda’s Lexington office.  Prior to joining Shire, Tom lead the Logistics and Supply Chain Operations teams at two large Contract Manufacturing Organizations.  Tom has been responsible for the implementation of multiple ERP systems / IRT solutions at a number of organizations throughout his career.  These software solutions include SAP, Oracle, as well as a number of software applications developed “in-house”.  Tom has over 15 combined years of Clinical Supply experience from both the CMO and Pharma sides of the industry.

Next speaker
Back
Bobbie L Whiddon
Supervisory Consumer Safety Officer, Division Of Northeast Imports, Office Of Regulatory Affairs (ORA), U.S. Food & Drug Administration

Bobbie Whiddon is presently the supervisor over the FDA imports group in Philadelphia.   He has been with the FDA for almost nine years.  Bobbie has acquired over 20 years of public health and environmental health experience through various positions in both government and industry.

FDA determines whether products are admissible into U.S. commerce and may refuse entry to any that violate or appear to violate any provisions of the Federal Food Drug and Cosmetic Act (FFD&C Act). Importers of products intended for introduction into U.S. interstate commerce are responsible for ensuring that the products are safe, sanitary, and labeled according to U.S. requirements.  Imported products are subject to FDA inspection when offered for import at U.S. ports of entry. FDA may detain shipments of products offered for import if the shipments are found not to be in compliance with U.S. requirements. Both imported and domestically-produced foods must meet the same legal requirements in the United States.

Next speaker
Back
Amaury Jeandrain
Head Of Pharma Solutions Adoption, Life Sciences, N-SIDE

Amaury Jeandrain has a Master’s Degree in Business Engineering with a specialization in supply chain management. After working for a CRO, he joined N-SIDE where he supported the optimization of hundreds of trials from different indications and pharmaceutical companies, providing services ranging from risk-based optimization to clinical trial design and solving drug supply shortage problems. Amaury now leads a group of consultants, focusing on the extension of N-SIDE’s solutions.

Next speaker
Back
Maxime Derep
Clinical Supply Optimization Senior Solutions Engineer, N-SIDE

Maxime is an optimist and is passionate about problem-solving. He is a Senior Consultant and has been working at N-SIDE for over 4 years. He supports pharma partners with the optimization of multiple trials and programs from different therapeutics areas. He also helps those partners to understand the value of risk-based optimization and drive changes within their organizations. He loves to exchange ideas and discuss with people from the industry. Maxime has a Master in Business Engineering with a focus on supply chain.

Next speaker
Back
EVAN HAHN
VP North America, TSS,

Throughout my career, I have focused on driving innovation by applying sophisticated approaches to leveraging data to life sciences. My previous companies are recognized as industry leaders in their respective spaces; TSS clearly fits that mold in the area. At Medidata, the leading eClinical platform provider, I led the growth of the of their RTSM solution from product startup to an industry leader. Responsibilities included RTSM go-to-market strategy, solution roadmap development, subject matter expert consulting, strategic partnership development Had the opportunity to meet with 100’s of supply chain leaders globally, gaining broad insights into the challenges they face Received feedback from large pharma, startup biotech’s, CRO’s, and regulatory agencies such as the FDA, and the NCI on biopharma supply challenges. Served as a delegate to the FDA to promote innovation in clinical trial approaches At Cytel, a company that provides analytical software and knowledge intensive services, I promoted the industry adoption of adaptive clinical trial designs to streamline drug development Have been an invited speaker at various conferences discuss topics including adaptive clinical trials, drug supply forecasting, and supply management technologies.

Next speaker
Back
Steve Siron
Statistical Design & Trial Supplies Consultant, CALYX
Next speaker
Back
George Amerson
Biological Threat Exclusion Coordinator, U.S. Customs And Border Protection

George Amerson is a Biological Threat Exclusion Coordinator (BTEC) for CBP in the Office of Field Operations/ Agriculture Programs and Trade Liaison/ Biological Threat Exclusion. As a BTEC, Mr. Amerson is charged with supporting and developing U.S. Customs and Border Protection (CBP) operational capacity and capability in preventing tools of agro/bio-terrorism from entering the U.S. Mr. Amerson has more than 16 years of public service with CBP and has worked in a variety of environments, including air passenger, maritime, cargo and CBP Training Academy.

Next speaker
Back
Gabriela Gottlieb
Associate Director Clinical Quality Assurance, Fujirebio Diagnostics

Gabriela Gottlieb is an Associate Director of Clinical Quality Assurance at Astellas Pharmaceuticals, where she drives Clinical QA activities related to management of risks, non-compliance and auditing across a therapeutic program to treat Prostate Cancer. In this capacity she interacts with executive level management, external vendors, collaboration partners, clinical study and cross-functional groups to ensure compliance with regulations, Astellas business practices and clinical research program objectives. Prior to Astellas, Gabriela served in a variety of roles in the Medical Device industry in areas of Interventional Oncology, Orthopedics and Interventional Cardiology. She has a track record of implementing quality systems in Clinical Research and Regulatory Affairs. She also has led several regulatory inspections with FDA, EMA and other global regulatory bodies. She bases her approach to program implementation through change management principles with a focus on data integrity, human subject protection and quality.

Next speaker
Back
Shanna Jackson
Senior Director, Vendor Management & Strategy, Taysha Gene Therapies

Experienced Clinical Operations professional with a demonstrated history of working in the pharmaceutical industry across multiple functions (research, development, operations, and outreach). I have had the privilege of being intimately involved in the development of a global orphan Oncology program from IND to NDA/MAA, commercialization, and post-market life cycle management. I look forward to the next opportunity that will directly contribute to the improvement of patients lives.

Next speaker
Back
HANEEN MAZAHREH-BOIVERT
President, Pivot

Haneen Mazahreh-Boivert is a global clinical supply expert and end to end supply chain advocate.  Throughout her 15+ year career, she has worked and consulted for numerous companies of varying footprints.  Haneen has successfully established and led numerous clinical supply chains from forecasting and planning, to vendor selection and management, clinical manufacturing and global distribution, to site management and drug accountability.  Her mantra is the right supplies at the right place at the right time and focuses her knowledge of operational excellence, KPI improvement, and process optimization to achieve this goal and build efficiencies into her projects. 

She is a graduate of the American University, Rowan University, and Yale University with BS. Chemical Engineering, MS. Chemical Engineering, and Certification of Executive Leadership respectively.  Haneen is active in the Global Clinical Supply circuit, has published several articles and regularly speaks at industry conferences.  She is also active in Women in Engineering groups.   

Next speaker
Back
Charlotte Moser
Chief Medical Officer, Deka Biosciences

Dr. Moser is an oncologist who has worked as a clinician and academic researcher for over 20 years and specialized in drug development for the past 10. She completed her PhD in Statistics working at the EORTC in Brussels and has led many multi-institutional trials and related cancer survivorship projects since. After completing her MBA at MIT Sloan School of Management (2017), she moved to the US and shifted focus from academic to commercial research. She has helped drive the clinical pipeline from early to late stage in larger (Elekta, Roche) and smaller (Augmenix, Kaiku, Artidis, Galera Therapeutics) companies and commercialization of several products including the post-marketing performance. Dr. Moser has obtained extensive clinical operational and regulatory experience dealing with different stakeholders (academic, industry, policymakers and patient advocates). Dr. Moser has helped direct the investment in private owned drug-development, as well as new cancer centers worldwide and was instrumental in launching Portugal’s National Cancer Institute. Dr. Moser previously served as the Vice President for Clinical Development for Galera Therapeutics, with who she went IPO in 2019 and SVP Clinical Strategy for ELEKTA Inc, a global radiation oncology device vendor (2017-2018). She founded Nanocan Therapeutics Corporation in 2020 and serves as the Chief Scientific Officer. Working with different academic groups she obtained over 5M of NIH-STTR awards to drive preclinical research and opening first in-human trials.

Next speaker
Back
Pedro J Rodriguez-Cardona
Clinical Supply Operations Manager, Janssen Research & Development, LLC

Experienced Leader with a demonstrated history of working in the pharmaceuticals industry. Strong operations professional, skilled in U.S. Food and Drug Administration (FDA), Verification and Validation (V&V), Life Sciences, GMP, Supplier Management and Six Sigma.

Next speaker
Back
ADAM BRADBURY
Analyst, GlobalData
Next speaker
Back
Jennifer L. Northcott
Director, West Point Clinical Supply Operations, Merck

An agile CPM certified project manager currently working within the clinical supply chain managing a team of project managers eager to optimize and strength the the supply chain and get medicine to patients more efficiently.

Prior 13 years of pharmaceutical experience, 5 years' managing clinical trials and 8 years’ experience executing high level scientific engagement meetings for various therapeutic areas, orchestrating cross-functional presence at international and national congresses, and managing clinical and pre-clinical investigator initiated trials.

Next speaker
Back
Frank Leu
CEO, Novapeutics,

Frank Leu is a Co-Founder and CEO of Novapeutics at Philadelphia, PA - a biopharma spun-out from the University of Pennsylvania, developing a first-in-class small molecule beta-cell restoration curative for type 2 diabetes. Prior, Frank was at a specialty pharma Verto Institute, developing biologic therapeutics for treating the neuroendocrine cancer. Frank graduated with a Pharmacology Ph.D. from Weill Cornell Graduate School of Medical Sciences in 2001, and then post-doc in a Howard Hughes Medical Institute laboratory at the Rockefeller University in molecular enzymology. He has served as an adjunct instructor at the Rutgers Cancer Institute of NJ, and is an adjunct professor at the pharmacology department of the Thomas Jefferson Medical University. Frank also founded BioPharMatrix developing blockchain solutions to lifescience innovations at all phases, and serves as advisor to the Pennovations center working with 1776 / Benjamins Desk. Frank is a thought leader in the blockchain architecture innovations in the life-sciences and drug development, Frank serves on multiple advisory boards and frequently served as chairman, speaker, moderator, and facilitator for many life-sciences and drug development events.

Next speaker
Back
ELVIRA D’MELLO
Director Data And Digital Transformation, Clinical Supply Chain Technology, Bristol Myers Squibb

Summary: Leader in digitization excellence and technology transformation for Clinical Supply Chain in Bristol Meyers Squibb. Results driven problem solver with cross-functional business expertise and technical knowledge, delivering success in energizing operational and systematic transformation.

Next speaker
Back
GORDON GREGORY
Clinical Supply Integrator & Operations Lead, Janssen Research & Development (Tentative)

Gordon Gregory III, CCRP began his career in the Document Management field of Clinical Research Operations in 2008. He moved quickly from a Document Management Associate, through various Clinical Trial Associate roles, into Global Trial Leadership as a Clinical Trial Manager and GCDO Trial Leader and is currently forming a group within Clinical Supply Chain to oversee all of the patient scheduling on Janssen's CAR-T trials. In his 12 years in the industry, he has excelled at every turn and was even selected to be a part of the initial cohort of the GCDO Clinical Operations Leaders of Tomorrow Program.

Next speaker
Back
Anis Ghossain
Enterprise Supply Chain Analytics, Bristol Myers Squibb

Anis has an MBA from Rutgers University with a specialization in Supply Chain Management and Data Analytics . In my employment thus far, I've achieved a record of success in Electrical/Mechanical Engineering, Supply Chain Management, Business Analytics and Project Management.

Anis’s key personal strengths include his ability to manage diverse teams, strategic thinking in optimizing processes and delivering results. Anis has extensive software knowledge, with proficiency in SAP, AWS, R, Python, Tableau, Spotfire and SQL; I'm also fluent in English, French, and Arabic.

Specialties: Electrical/mechanical engineering, supply chain end to end visibility, distribution and transportation management, project management, data science, supply chain digitization & control tower.

Next speaker
Back
Sean Walsh
Executive Director, Quality & Chief Compliance Officer, Adlai Nortye Biopharma

Experienced Technical Operations Lead with a demonstrated history of advancing clinical development programs in the biotechnology industry. Strong operations professional skilled in Manufacturing, Development, Supply Chain and Quality Operations for both large pharma and small biotech.

Next speaker
Back
Bharat Dixit
Chief Technology Officer, Adiso Therapeutics
Next speaker
Back
Francesco Santo
Associate Director, Clinical Supplies, Exelixis

Francesco Santo has been establishing his career and reputation in the clinical supply project management world for over 16 years.  His experience includes both large pharma and small pharma backgrounds.  He has a true passion for this industry, specifically the project management of clinical trial drug supply.  What motivates him to continue progressing in this industry is his passion for the patients on the other end of the table.  Patients first mentality is what brought him to his current level of employment 

Session Details:

CORE Elements of a Clinical Supply Project Manager

2023-10-19, 9:00 AM

View In Agenda
Next speaker
Back
Sean Smith
Biological Threat Exclusion Coordinator, US Customs And Border Protection

Sean Smith is a Biological Threat Exclusion Coordinator (BTEC) for CBP in the Office of Field Operations/ Agriculture Programs and Trade Liaison/ Agro/Bio-Terrorism Countermeasures. As a BTEC, Mr. Smith is charged with supporting and developing U.S. Customs and Border Protection (CBP) operational capacity and capability in preventing tools of agro/bio-terrorism from entering the U.S.

Mr. Smith joined CBP in 2005 as an Agriculture Specialist (CBPAS) and was promoted to Supervisory CBPAS in 2008. He has served CBP in the following ports of entry: San Diego, San Ysidro, Otay Mesa and Boston Logan Airport. From 2011- 2018, Mr. Smith served as the primary Public Affairs Liaison and Border Community Liaison, respectively, for CBP in New England. He has also volunteered to assist in past domestic and international CBP disaster recovery operations, including: Hurricane Ike (2008), 'Operation Safe Return' (Haitian Relief Effort- 2010), and Hurricane Harvey, DHS Surge Capacity Force (2017).

Prior to CBP, Mr. Smith contributed to wildlife conservation for nearly a decade, completing field work on rare endemic Hawaiian birds on the Big Island of Hawaii, and raising rare and endangered birds (in some cases, extinct in the wild) at the San Diego Zoo's Avian Propagation Center. Also, Mr. Smith is a former reserve firefighter and EMT for the City of Borrego Springs in California. He holds a Bachelor of Science degree in Ecology and Systematic Biology from Cal Poly San Luis Obispo, California.

Mr. Smith, his wife, two children, one dog, and one chicken live in an old farmhouse in Massachusetts.

Next speaker
Back
Joshua Anderson
Manager, Logistics Strategy Clinical Supply Chain, Janssen Research & Development

Senior logistics and supply chain professional with extensive experience leading across pharmaceutical and healthcare firms. Unique educational background in biology/chemistry combined with a MBA in Supply Chain Management. Expertise in managing research, clinical and commercial activities with regards to strategic planning, forecasting and design of high quality and cost-effective production through distribution of finished goods.

Next speaker
Back
Diego Montemeyor
Sr Manager Global Trade Compliance, CSL Behring
Next speaker
Back
Nick Spring
CEO, FluoroMe

Experienced, results-oriented executive with a strong track record of team building, strategic planning and tactical execution in high-paced organizations in med-devices, pharma, biotech, digital transformation - human and animal health. Utilizes keen analysis and insights and a collaborative team approach to drive commercialization, project planning, organizational improvements and implementation of best practices. Superior interpersonal skills, capable of resolving multiple and complex issues and motivating staff to peak performance. A leader with proven skills in:

• Management & Leadership
• Business Operations & Strategy
• Effective Communication & Delegation
• Adaptability & Determination
• Forward Thinking & Calculated Risk Management
• Working with investors & stakeholders
• FDA compliant development & launch
• Passion for healthcare devices, digital transformation, biotech, pharmaceuticals, consumer and professional products/brands

Next speaker
Back
Kim Buchanan
Associate Director Development Quality, Merck

Experienced quality professional with strong leadership and exceptional background in packaging operations, technology, clinical supplies, commercial products, laboratory, and FDA & EU regulatory agency compliance and inspections. Cross functional roles include 2 interim clinical supply assignments, direct line supervision of Global Quality, Sterile & Biological Operations/Technology and Pharm Laboratory personnel.  Key in the development of Expanded Access Program at her company.

Next speaker
Back
Ginelle Andrews
Director Commercial Product Sourcing Strategy, Pfizer
Next speaker

2022 Sponsors

Select a sponsor to learn more

FEATURED SPONSORS

SESSION SPONSORS

TECHNOLOGY SPOTLIGHT SPONSORS

ASSOCIATE SPONSOR

EXHIBITORS

Media Centre

MEDIA PARTNERS

Become A Media Partner

Bringing together Pharma and Biotech experts to discuss new trends and opportunities

 

The Clinical Trial Supply East Coast is the meeting place for the pharmaceutical and biotechnology community to discover how to excel in clinical supply strategy as well as form key connections for long-term success.

 

It’s time to build relationships and take away valuable lessons to for clinical trial success moving forward so we look forward to seeing you there!

See What It's All About

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Jaz Sidhu

Senior Sponsorship Manager

+44 (0) 207 9472755

SPEAKER ENQUIRIES

Douglas Webber

Conference Producer

MARKETING ENQUIRIES

Moona Popal

Marketing Manager

SPONSORSHIP ENQUIRIES

To enquire about sponsorship opportunities for the conference, please contact:

Jaz Sidhu

Senior Sponsorship Manager


+44 (0) 207 9472755

SPEAKER ENQUIRIES

To enquire about speaking opportunities for the conference, please contact:

Douglas Webber

Conference Producer